Home / Inspections / 1037302

FDA Inspection 1037302 — Louisville Reproductive Center

Louisville Reproductive Center — FEI 3005081370

The FDA completed an inspection of Louisville Reproductive Center on January 4, 2018 in Louisville, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 4, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Louisville, KY (United States)

Facility

Other inspections at this facility

  • 1268429 (OAI Mon Apr 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1215469 (NAI Tue Aug 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1172027 (NAI Tue Jun 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1139891 (NAI Thu Apr 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1014448 (OAI Thu Jun 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources